RA
ANAC

Royce & Associates’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Royce & Associates’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-58,500
Closed -$6.61M – 1179
2015
Q4 		$6.61M Sell
58,500
-61,000
-51% -$6.72M 0.04% 538
2015
Q3 		$14.1M Sell
119,500
-40,000
-25% -$5.22M 0.07% 322
2015
Q2 		$12.3M Sell
159,500
-125,000
-44% -$8.2M 0.05% 465
2015
Q1 		$16.5M Sell
284,500
-56,000
-16% -$2.38M 0.06% 400
2014
Q4 		$11M Hold
340,500
– – 0.04% 563
2014
Q3 		$8.33M Buy
+340,500
New +$6.92M 0.03% 668

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Royce & Associates's ANAC Position: Q1 2016 in Review

Royce & Associates sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016, closing a stake of 58,500 shares — an estimated $6.61M sold.

Royce & Associates first reported a position in ANAC in Q3 2014 and held it in 6 quarters. The position peaked at $16.5M in Q1 2015. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

  • Royce & Associates reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
  • Royce & Associates sold 58,500 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $6.61M.
  • Royce & Associates first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2014 and held it in 6 quarters.
  • Royce & Associates's ANACOR PHARMACEUTICALS INC COM position peaked at $16.5M in Q1 2015.
  • 199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on Royce & Associates's 13F filing for Q1 2016, filed 11 May 2016.